Skip to content

Clinical study on Toothpastes for toothache, dental caries and oral hygiene

Evaluation of efficacy and safety of toothpastes against baseline and against each other in relief from hypersensitivity, improvement in the dental condition for toothache, dental caries and oral hygiene

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/11/005212
Enrollment
120
Registered
2014-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified Health Condition 2: K039- Disease of hard tissues of teeth,unspecified

Interventions

Intervention1: Dabur Red Toothpaste: Dabur Red Toothpaste contains: Maricha (Piper nigrum), Pippali (Piper longum), Shunti (Zingiber officinale), Tomar beej (Zanthoxylum armatum), Lavang oil (Oil of

Sponsors

Dabur India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Subjects with age group 12-65 years in general good health and oral health. •Subjects should have at least one tooth from which a painful response could be elicited by both a dental explorer and air blast. •Subjects having ICADS score of less than 2 concerning dental caries. •Subjects having extrinsic dental stains and bad oral hygiene. •Subjects willing to give a voluntary written informed consent for photography release and agree to come for regular follow up. •Subjects willing to abide by and comply with the study protocol. •Subjects who have not participated in a similar investigation in the past four weeks. •Subjects who will be available for the entire duration of the study. •Subjects who are willing not to participate in any other clinical study during participation in the current study.

Exclusion criteria

Exclusion criteria: •A known history or present condition of hyper sensitivity to any tooth paste. •The use of antibiotic, antimicrobial, analgesic medications, mouthwash or desensitizing toothpaste during the previous 1 month. •Any history of periodontal therapy by surgical interventions. •Any history of dentine hypersensitivity treatment. •Orthodontic treatment with ï¬?xed appliances. •Any removable device such as a removable partial denture or orthodontic retainer. •The presence of any ï¬?xed appliance, large or defective restorations, cracked enamel, or caries on the History hypersensitive tooth. •History of smoking or smokeless tobacco products. •Subjects having intrinsic dental stains. •Subjects having abnormal frenum attachment. •Subjects who are pregnant, lactating or nursing. •Subjects having severe level of calculus and/ tartar. •Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness.

Design outcomes

Primary

MeasureTime frame
ï?¶ Reduction of toothache in relation to hypersensitivity in comparison to baseline. ï?¶ Optimum protection of dental caries in comparison to baseline.Timepoint: 5 visits Visit 1 (Screening), Visit 2 (baseline), Visit 3 (Week 4), Visit 4 (Week 12) & Visit 5 (Week 24).

Secondary

MeasureTime frame
ï?¶Reduction of plaque in comparison to baseline. ï?¶Reduction of halitosis in comparison to baseline. ï?¶Reduction of dental stains in comparison to baseline. ï?¶Improvement of overall oral hygiene in comparison to baseline. ï?¶Superiority of one of the test products in comparison to the other test products. ï?¶Acceptance of the test products by sensorial evaluation by subject self assessment questionnaire. ï?¶To assess gingiva, oral mucosa & lips for safety of the test products.Timepoint: 5 visits Visit 1 (Screening), Visit 2 (baseline), Visit 3 (Week 4),;ï?¶Reduction of plaque in comparison to baseline. ï?¶Reduction of halitosis in comparison to baseline. ï?¶Reduction of dental stains in comparison to baseline. ï?¶Improvement of overall oral hygiene in comparison to baseline. ï?¶Superiority of one of the test products in comparison to the other test products. ï?¶Acceptance of the test products by sensorial evaluation by subject self assessment questionnaire. ï?¶To assess gingiva, oral mucosa & lips for safety of the test products.Timepoint: 5 visits Visit 1 (Screening), Visit 2 (baseline), Visit 3 (Week 4),

Countries

India

Contacts

Public ContactDr Vinayak R

Dabur India Limited

arun.gupta@dabur.com1203378614

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026